Perceptive Advisors LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Perceptive Advisors LLC disclosed 97 US equity positions worth $3.6bn in its Q4 2024 13F filing. The largest position was VRNA at 8.3% of the reported book, followed by ACLXGBX and AM6. Against the Q3 2024 filing, it opened 5 new positions, added to 9 and reduced 25 among the top 50 holdings.
What did Perceptive Advisors LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | VRNA VERONA PHARMA PLC | 8.3% | $296.8m | 6,392,106 | 1% | added | |
| 2 | ACLXGBX ARCELLX INC | 7.4% | $266.8m | 3,478,888 | -11% | reduced | |
| 3 | AM6 AMICUS THERAPEUTICS INC | 6.4% | $228.4m | 24,245,952 | -14% | reduced | |
| 4 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 5.7% | $206.0m | 3,680,473 | 3% | added |
| 5 | NUVALENT INC | 5.7% | $205.1m | 2,619,977 | -12% | reduced | |
| 6 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 4.6% | $163.6m | 22,112,266 | -17% | reduced |
| 7 | PCVX VAXCYTE INC | Healthcare | 3.9% | $140.7m | 1,718,417 | -15% | reduced |
| 8 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 3.0% | $107.6m | 1,288,328 | -21% | reduced | |
| 9 | CNTA CENTESSA PHARMACEUTICALS PLC | 3.0% | $106.3m | 6,349,220 | 1% | added | |
| 10 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.9% | $102.3m | 1,329,735 | 14% | added |
| 11 | AORT ARTIVION INC | Healthcare | 2.2% | $79.9m | 2,793,703 | 0% | held |
| 12 | MGTX MEIRAGTX HLDGS PLC | 2.1% | $76.6m | 12,581,103 | 0% | held | |
| 13 | EWTX EDGEWISE THERAPEUTICS INC | 2.0% | $71.7m | 2,685,537 | 15% | added | |
| 14 | SLNOEUR SOLENO THERAPEUTICS INC | 1.9% | $67.5m | 1,501,040 | -53% | reduced | |
| 15 | IMTX IMMATICS N.V | Healthcare | 1.9% | $66.7m | 9,383,456 | 16% | added |
| 16 | PODD INSULET CORP | Healthcare | 1.7% | $60.6m | 232,269 | 63% | added |
| 17 | SYRE SPYRE THERAPEUTICS INC | 1.7% | $59.9m | 2,574,723 | -10% | reduced | |
| 18 | CATBUSD ASTRIA THERAPEUTICS INC | 1.6% | $58.0m | 6,485,420 | 0% | held | |
| 19 | EOLS EVOLUS INC | Healthcare | 1.6% | $56.8m | 5,145,846 | -4% | reduced |
| 20 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 1.6% | $56.2m | 664,074 | -15% | reduced |
| 21 | CRGX CARGO THERAPEUTICS INC | 1.5% | $53.1m | 3,683,004 | 0% | held | |
| 22 | IMVT IMMUNOVANT INC | Healthcare | 1.5% | $53.0m | 2,139,199 | -10% | reduced |
| 23 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.4% | $49.1m | 1,271,662 | -7% | reduced |
| 24 | APGE APOGEE THERAPEUTICS INC | Healthcare | 1.3% | $47.4m | 1,047,232 | -48% | reduced |
| 25 | ALDX ALDEYRA THERAPEUTICS INC | Healthcare | 1.3% | $46.3m | 9,275,851 | 0% | held |
| 26 | JANX JANUX THERAPEUTICS INC | Healthcare | 1.2% | $43.8m | 817,895 | – | new |
| 27 | ARGX ARGENX SE | Healthcare | 1.2% | $41.5m | 67,471 | -43% | reduced |
| 28 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.1% | $40.1m | 995,894 | -41% | reduced |
| 29 | AKERO THERAPEUTICS INC | 0.9% | $33.0m | 1,185,592 | -31% | reduced | |
| 30 | ISRG INTUITIVE SURGICAL INC | Healthcare | 0.9% | $32.9m | 63,119 | 9% | added |
| 31 | ACRV ACRIVON THERAPEUTICS INC | 0.9% | $32.3m | 5,360,858 | 0% | held | |
| 32 | ZYME ZYMEWORKS INC | Healthcare | 0.9% | $31.2m | 2,130,020 | -2% | reduced |
| 33 | CELC CELCUITY INC | Healthcare | 0.9% | $30.9m | 2,362,279 | 0% | held |
| 34 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.8% | $28.5m | 1,486,508 | -47% | reduced |
| 35 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.8% | $27.6m | 6,906,646 | 0% | held |
| 36 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.7% | $25.6m | 6,774,348 | 219% | added |
| 37 | PRCT PROCEPT BIOROBOTICS CORP | Healthcare | 0.7% | $23.4m | 290,659 | -8% | reduced |
| 38 | NAUT NAUTILUS BIOTECHNOLOGY INC | 0.6% | $21.2m | 12,594,211 | 0% | held | |
| 39 | CTNM CONTINEUM THERAPEUTICS INC | 0.6% | $21.1m | 1,441,249 | -5% | reduced | |
| 40 | NTRA NATERA INC | Healthcare | 0.6% | $19.8m | 125,000 | -43% | reduced |
| 41 | IKT INHIBIKASE THERAPEUTICS INC | 0.5% | $19.3m | 5,925,000 | – | new | |
| 42 | OBIO ORCHESTRA BIOMED HLDGS INC | 0.5% | $18.4m | 4,592,556 | 0% | held | |
| 43 | PEN PENUMBRA INC | Healthcare | 0.5% | $17.4m | 73,338 | – | new |
| 44 | SEPN SEPTERNA INC | 0.5% | $17.2m | 750,000 | – | new | |
| 45 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.5% | $16.4m | 845,567 | -32% | reduced |
| 46 | INBX INHIBRX BIOSCIENCES INC | 0.5% | $16.4m | 1,064,026 | 0% | held | |
| 47 | ADMA ADMA BIOLOGICS INC | Healthcare | 0.4% | $15.3m | 890,280 | -16% | reduced |
| 48 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.4% | $14.5m | 403,649 | – | new |
| 49 | ARVN ARVINAS INC | Healthcare | 0.4% | $14.2m | 740,749 | -28% | reduced |
| 50 | NBIX NEUROCRINE BIOSCIENCES | Healthcare | 0.4% | $13.7m | 100,050 | -53% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.